Drug of Abuse (DOA)

Cocaine (COC) Rapid Test

Detects Benzoylecgonine. colloidal-gold. Specimen: Urine.

Target / Analyte	Benzoylecgonine
Disease / Indication	Drug screening
Series	Drug of Abuse (DOA)
Method	colloidal-gold
Specimen	Urine
Regulatory	CE · FDA
OEM/ODM	Available — private label & custom panel

Direct Answer

This rapid test detects Benzoylecgonine in Urine to support Drug screening. It is a colloidal-gold screening test — a reactive result is presumptive and should be confirmed per the intended use.

Intended Use

Detection of benzoylecgonine (cocaine metabolite) in urine.

Clinical Context

Cocaine screening; cut-offs 100–300 ng/mL.

Test Principle

Colloidal-gold immunochromatography (lateral flow). The device captures the target analyte (antigen or antibody) on a membrane via labeled antibodies, producing a visible test line within minutes. Qualitative or semi-quantitative, intended as a screening/triage aid — not a replacement for confirmatory laboratory testing.

Limitations

Presumptive positive requires confirmation.

Procurement

Specimen: urine. Format: cassette / dipstick / panel. CE-marked line (FDA status per product on request).

Interpretation

Result	Lines	Meaning
Positive	Test + control line	Target detected (presumptive positive)
Negative	Control line only	Below cut-off / not detected
Invalid	No control line	Repeat with a new device

Available SKUs (this series)

Cat. No.	Product	Specimen	Format	Kit Size	Status
DCO-102	COCAINE (COC) Rapid Test Cassette	Urine	Cassette	40 T	CE/FDA
DCO-114	COCAINE (COC) Rapid Test Panel	Urine	Panel	40 T	CE/FDA
DCO-101	COCAINE (COC) Rapid Test Dipstick	Urine	Dipstick	50 T	CE/FDA
DCO-802	COCAINE (COC) Rapid Test Cassette	Oral Fluid	Cassette	25 T	CE
DCO-803	COCAINE (COC) Rapid Test Midstream	Oral Fluid	Midstream	25 T	CE

Documentation & quotation — datasheet, IFU, MOQ and OEM/ODM options on request.

Request IFU / Spec Sheet Request Datasheet

Last reviewed: 2026-09-12